Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CerAxon citicoline: IPIC began its fourth Phase III trial

(Ferrer licenses citicoline rights, B4)

Interneuron Pharmaceuticals

Read the full 79 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE